Ohio Bioscience News

Click a news item to be directed to the full story. Send your news to bioohio@bioohio.com.

Found 7731 Results

Cleveland biotech developing sulfur molecules targeting oxidative stress-related disease

Cleveland biotechnology company Sulfagenix has secured a key patent related to its efforts to develop hydrogen sulfide prodrugs (inactive drug precursors converted into active form in the body by normal metabolic […]

January 31, 2013

I’d like to thank the Academy…

Actually we should thank the Austen BioInnovation Institute in Akron for this great idea. ABIA just announced a cool new educational initiative, the BioInnovation Academy, which starts this summer. The week-long summer […]

January 30, 2013

Brown announces bill to bolster pediatric research

One week before Madison Reed, a Dublin teenager who is living with Spinal Muscular Atrophy (SMA) turns 16, U.S. Sen. Sherrod Brown yesterday joined the Reed family at Nationwide Children’s […]

January 29, 2013

Case/UH researchers discover promising biomarker for aggressive breast cancer

A team of researchers led by Goutham Narla, MD, PhD, at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center have discovered a gene variant that […]

January 28, 2013

UC Brain Tumor Center testing thousands of compounds in search for glioblastoma breakthrough

James Driscoll, MD, PhD, and his team of researchers at the Brain Tumor Center at the University of Cincinnati Neuroscience Institute are testing more than 2,000 different small-molecule compounds for signs […]

January 25, 2013


Cincinnati foundation awards over $1.5 million for pediatric neuro research

The International Rett Syndrome Foundation (IRSF) accelerated its efforts to produce treatments for Rett syndrome and related disorders, announcing today that it is awarding another $1.5 million to support 18 new […]

January 22, 2013



Navidea, AstraZeneca complete Alzheimer’s biomarker study

Navidea Biopharmaceuticals, a Dublin, Ohio biopharmaceutical company focused on precision diagnostics, earlier this week announced the completion of a study of its novel radiopharmaceutical NAV4694 as a biomarker for Alzheimer’s […]

January 18, 2013